CCJ vs NXE Comparison: AI Score, Valuation, Performance and Upside
CCJ holds the edge across 3 of 5 key metrics in this comparison. NXE has delivered stronger 1-year price return (+10.02% vs +9.77%), though CCJ has the better forward P/E setup (50.78x vs -54.76x for NXE). Analyst consensus implies meaningfully more upside for NXE (+90.00%) than for CCJ (+35.99%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
| Metric | CCJ | NXE |
|---|---|---|
| AI scorei | 59.6 | 39.2 |
| AI ranki | #151 | #1174 |
| Latest closei | $94.56 | $9.82 |
| 1M returni | -7.76% | -9.53% |
| 6M returni | -12.48% | -15.52% |
| 1Y returni | +9.77% | +10.02% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | CCJ | NXE |
|---|---|---|
| 1Y ago | $11K (+10.0%) started 2025-09-22 | $11K (+10.0%) started 2025-09-22 |
| 5Y ago | $46.13K (+361.3%) started 2021-09-22 | $20.47K (+104.7%) started 2021-09-22 |
| 10Y ago | $123.54K (+1135.4%) started 2016-09-22 | $61.44K (+514.4%) started 2016-09-22 |
Hypothetical — past performance does not guarantee future results.
| Metric | CCJ | NXE |
|---|---|---|
| Market capi | $41.68B | $6.85B |
| Trailing P/Ei | 162.20 | N/A |
| Forward P/Ei | 50.78 | -54.76 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 12.10 | N/A |
| Analyst targeti | $130.14 | $19.42 |
| Target upsidei | +35.99% | +90.00% |
| Metric | CCJ | NXE |
|---|---|---|
| Revenue growthi | -7.20% | N/A |
| Earnings growthi | -92.10% | N/A |
| EPS growthi | -92.10% | N/A |
| FCF margini | +1.44% | N/A |
| Operating margini | 9.11% | 0.00% |
| Profit margini | 10.21% | 0.00% |
| ROIC proxyi | 5.11% | -17.67% |
| Return on equityi | 5.11% | -17.67% |
| Dividend yieldi | 0.18% | N/A |
| Payout ratioi | 29.63% | 0.00% |
| Dividend growth streaki | 2 yrs | N/A |
| Betai | 0.99 | 1.65 |
| Debt/equityi | 17.13 | 33.57 |
| Current ratioi | 3.06 | 1.46 |
| Quick ratioi | 1.88 | 1.44 |
Over the past year, CCJ and NXE have moved strongly in the same direction (correlation of 0.84), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | CCJ | NXE |
|---|---|---|---|
| 1Y | Growthi | +9.77% | +10.02% |
| CAGRi | +9.78% | +10.03% | |
| Volatilityi | 54.92% | 55.81% | |
| Sharpe ratioi | 0.36 | 0.37 | |
| Sortino ratioi | 0.56 | 0.54 | |
| Max drawdowni | 36.93% | 37.28% | |
| Current drawdowni | 29.48% | 29.42% | |
| Avg drawdowni | 16.24% | 15.70% | |
| Ulcer Indexi | 18.95% | 18.88% | |
| Max daily dropi | 9.28% | 9.90% | |
| Max wkly dropi | 18.25% | 20.18% | |
| 5Y | Growthi | +355.65% | +104.69% |
| CAGRi | +35.44% | +15.41% | |
| Volatilityi | 49.69% | 57.43% | |
| Sharpe ratioi | 0.77 | 0.46 | |
| Sortino ratioi | 1.17 | 0.68 | |
| Max drawdowni | 40.01% | 54.28% | |
| Current drawdowni | 29.48% | 29.42% | |
| Avg drawdowni | 13.80% | 22.54% | |
| Ulcer Indexi | 17.24% | 26.12% | |
| Max daily dropi | 15.16% | 15.88% | |
| Max wkly dropi | 21.23% | 24.61% | |
| 10Y | Growthi | +1041.21% | +514.45% |
| CAGRi | +27.57% | +19.91% | |
| Volatilityi | 46.91% | 61.64% | |
| Sharpe ratioi | 0.66 | 0.53 | |
| Sortino ratioi | 0.99 | 0.82 | |
| Max drawdowni | 57.22% | 82.98% | |
| Current drawdowni | 29.48% | 29.42% | |
| Avg drawdowni | 16.13% | 29.22% | |
| Ulcer Indexi | 19.23% | 34.08% | |
| Max daily dropi | 18.24% | 17.42% | |
| Max wkly dropi | 26.82% | 29.30% |
| Category | CCJ | NXE |
|---|---|---|
| Company | CCJ | NXE |
| Sector | Energy | Energy |
| Industry | Uranium | Uranium |
| Core business | Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia. | NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, evaluation, and development of uranium properties in Canada. |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.